Form 4 for HAE HAEMONETICS CORP
Accepted 2024-05-08 00:00:00 ET · period of report 2024-05-06 · accession 0001127602-24-014594 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-08 | 2024-05-06 | HAE | Lingamneni Anila | EVP, CTO | S - Sale | $95.00 | -2,305 | 12.3K | -16% | -$219.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-06 | S | D | 2,305 | $95.00 | 12,295 | D | — | — | (F2) This number includes unvested restricted stock units previously reported as well as 289 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024. |